Dr. Issa discusses infection prevention and management after stem cell transplant, focusing on how infection risks change throughout the transplant journey. The presentation covers common bacterial, fungal, and viral infections; the impact of immunosuppression and GVHD; vaccination recommendations; and practical strategies to reduce infection risk. Dr. Issa also addresses questions about water safety, COVID-19 vaccination, shingles vaccination, and the development of a CMV vaccine.

This presentation provides an overview of common infections seen after transplant or CAR-T therapy, outlines treatment options and explains steps both patients and physicians can take to reduce the risk of developing infections.

People who undergo a stem cell transplant or CAR T-cell therapy have an increased risk of infection after treatment. This presentation discusses who’s at risk, when infections typically arise, steps taken by transplant teams to avoid and treat infections and steps patients can take to reduce their risk of developing a serious infection.

Several types of infection can occur after a stem cell or bone marrow transplant and can complicate recovery for patients. This presentation describes the infection risks during the posttransplant period, therapies to treat them, and some measures to prevent them.

Distintos tipos de infecciones pueden ocurrir después de un trasplante y pueden complicar la recuperación de los pacientes. Esta presentación describe los riesgos de infecciones después de un trasplante, las terapias para tratarlas, y algunas medidas para prevenirlas.

The chemotherapy and/or radiation given to patients before a stem cell transplant compromise immunity and leave patients vulnerable to infections. This presentation describes major infection risks and effective responses to them. Many thanks to Takeda Pharmaceutical Company whose support, in part, made this presentation possible.